Figure 2
From: Tumor size improves the accuracy of the prognostic prediction of T4a stage colon cancer
Prognosis of CC patients who underwent curative surgery. Patients were categorized into two groups according to the tumor size: SG and LG. (A) Overall survival curve for all patients: the 5-year OS rates were 75.2% and 63.5% for SG and LG, respectively (P < 0.001). (B) Relapse-free survival for all patients: the 5-year RFS rates were 72.4% and 59.5% for SG and LG, respectively (P < 0.001). (C) Overall survival curve for matched patients: the 5-year OS rates were 75.2% and 58.7% for SG and LG, respectively (P < 0.001). (D) Relapse-free survival for matched patients: the 5-year RFS rates were 72.4% and 54.9% for SG and LG, respectively (P < 0.001).
